Skin vaccine using microneedle patch with inactivated RSV virus and an immune-stimulating compound as tested in mice is effective against RSV, a common respiratory disease that can be serious for young children. For children under 1 year old in the US, RSV is the most common cause of bronchiolitis.

Skin vaccine using microneedle patch with inactivated RSV virus and an immune-stimulating compound as tested in mice is effective against RSV, a common respiratory disease that can be serious for young children. For children under 1 year old in the US, RSV is the most common cause of bronchiolitis.: https://ift.tt/2S7x9tz Read more... https://ift.tt/2A34X3U